CLOs on the Move

Capio Partners

www.capiopartners.com

 
Capio Partners provides revenue cycle solutions for some of the nation`s leading healthcare providers and hospital systems, converting uncollected receivables into cash. As the healthcare industry moves towards purchasing solutions, Capio Partners offers leadership, knowledge, innovation, and unsurpassed results to help you maximize revenue and minimize risk.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.capiopartners.com
  • 2222 Texoma Parkway Suite 150
    Sherman, TX USA 75090
  • Phone: 903.892.7400
  • Fax: 903.893.4825

Executives

Name Title Contact Details

Similar Companies

Cempa Community Care

Our mission is to champion healthy communities by providing affordable, compassionate, and high-quality care.

Amerimed

Amerimed Medical Solutions is a healthcare company that provides emergency medical services and mobile integrated healthcare in several states in the US.

Symbria

At Symbria, we unite passion, insight, and performance to help senior-living and post-acute providers build sustainable success. We don`t make this commitment lightly, understanding full well how challenging this goal is to achieve in today`s demanding, highly competitive environment. Every service we provide – from therapy to pharmacy to wellness to benchmarking – is thoughtfully developed and conscientiously implemented to amplify your ability to effectively and cost-efficiently meet the needs of the residents and patients your community serves.

CanReg

CanReg, Inc. is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Metamark

Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.